Dialectic Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2018-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.dtsciences.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Study of DT2216 in Relapsed/Refractory Malignancies
- First Posted Date
- 2021-05-14
- Last Posted Date
- 2025-04-16
- Lead Sponsor
- Dialectic Therapeutics, Inc
- Target Recruit Count
- 20
- Registration Number
- NCT04886622
- Locations
- 🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸Mary Crowley Cancer Research, Dallas, Texas, United States
🇺🇸Mays Cancer Center, San Antonio, Texas, United States
News
No news found